286 related articles for article (PubMed ID: 38487527)
1. Approaches of dengue control: vaccine strategies and future aspects.
Akter R; Tasneem F; Das S; Soma MA; Georgakopoulos-Soares I; Juthi RT; Sazed SA
Front Immunol; 2024; 15():1362780. PubMed ID: 38487527
[TBL] [Abstract][Full Text] [Related]
2. Targets and strategies for vaccine development against dengue viruses.
Wang WH; Urbina AN; Lin CY; Yang ZS; Assavalapsakul W; Thitithanyanont A; Lu PL; Chen YH; Wang SF
Biomed Pharmacother; 2021 Dec; 144():112304. PubMed ID: 34634560
[TBL] [Abstract][Full Text] [Related]
3. Dengue vaccine candidates in development.
Durbin AP; Whitehead SS
Curr Top Microbiol Immunol; 2010; 338():129-43. PubMed ID: 19802583
[TBL] [Abstract][Full Text] [Related]
4. Detection of recombinant dengue virus 2 NS1 protein in
Abraham PR; Sankari T; Kumar NP; Kumar A
J Vector Borne Dis; 2022; 59(1):98-101. PubMed ID: 35708411
[TBL] [Abstract][Full Text] [Related]
5. Dengue virus vaccine development.
Yauch LE; Shresta S
Adv Virus Res; 2014; 88():315-72. PubMed ID: 24373316
[TBL] [Abstract][Full Text] [Related]
6. Recent Developments in Recombinant Protein-Based Dengue Vaccines.
Tripathi NK; Shrivastava A
Front Immunol; 2018; 9():1919. PubMed ID: 30190720
[TBL] [Abstract][Full Text] [Related]
7. Next-generation dengue vaccines: novel strategies currently under development.
Durbin AP; Whitehead SS
Viruses; 2011 Oct; 3(10):1800-14. PubMed ID: 22069516
[TBL] [Abstract][Full Text] [Related]
8. Dengue NS1 antigen kit shows high sensitivity for detection of recombinant dengue virus-2 NS1 antigen spiked with Aedes aegypti mosquitoes.
Abraham PR; R B; N PK; Kumar A
Sci Rep; 2021 Dec; 11(1):23699. PubMed ID: 34880307
[TBL] [Abstract][Full Text] [Related]
9. Vaccines and immunization strategies for dengue prevention.
Liu Y; Liu J; Cheng G
Emerg Microbes Infect; 2016 Jul; 5(7):e77. PubMed ID: 27436365
[TBL] [Abstract][Full Text] [Related]
10. Generation and preclinical evaluation of a DENV-1/2 prM+E chimeric live attenuated vaccine candidate with enhanced prM cleavage.
Keelapang P; Nitatpattana N; Suphatrakul A; Punyahathaikul S; Sriburi R; Pulmanausahakul R; Pichyangkul S; Malasit P; Yoksan S; Sittisombut N
Vaccine; 2013 Oct; 31(44):5134-40. PubMed ID: 23973247
[TBL] [Abstract][Full Text] [Related]
11. Limited Transmission Potential of Takeda's Tetravalent Dengue Vaccine Candidate by
Dietrich EA; Ong YT; Stovall JL; Dean H; Huang CY
Am J Trop Med Hyg; 2017 Nov; 97(5):1423-1427. PubMed ID: 28820715
[TBL] [Abstract][Full Text] [Related]
12. Using recombinant DNA technology for the development of live-attenuated dengue vaccines.
Lee HC; Butler M; Wu SC
Enzyme Microb Technol; 2012 Jul; 51(2):67-72. PubMed ID: 22664189
[TBL] [Abstract][Full Text] [Related]
13. Dengue vaccines: challenges, development, current status and prospects.
Ghosh A; Dar L
Indian J Med Microbiol; 2015; 33(1):3-15. PubMed ID: 25559995
[TBL] [Abstract][Full Text] [Related]
14. Current progress in dengue vaccines.
Wan SW; Lin CF; Wang S; Chen YH; Yeh TM; Liu HS; Anderson R; Lin YS
J Biomed Sci; 2013 Jun; 20(1):37. PubMed ID: 23758699
[TBL] [Abstract][Full Text] [Related]
15. Virus-like particle secretion and genotype-dependent immunogenicity of dengue virus serotype 2 DNA vaccine.
Galula JU; Shen WF; Chuang ST; Chang GJ; Chao DY
J Virol; 2014 Sep; 88(18):10813-30. PubMed ID: 25008922
[TBL] [Abstract][Full Text] [Related]
16. Current status and perspectives on vaccine development against dengue virus infection.
Park J; Kim J; Jang YS
J Microbiol; 2022 Mar; 60(3):247-254. PubMed ID: 35157223
[TBL] [Abstract][Full Text] [Related]
17. Releasing Intracellular NS1 from Mosquito Cells for the Detection of Dengue Virus-Infected Mosquitoes.
Cheng L; Liu WL; Li HH; Su MP; Wu SC; Chen HW; Pan CY; Tsai JJ; Chen CH
Viruses; 2020 Sep; 12(10):. PubMed ID: 33003584
[TBL] [Abstract][Full Text] [Related]
18. Detection of NS1 protein from dengue virus in excreta and homogenates of wild-caught Aedes aegypti mosquitoes using monoclonal antibodies.
Rodriguez MC; Cime-Castillo J; Argotte-Ramos R; Vargas V; Correa-Morales F; Sánchez-Tejeda G; Lanz-Mendoza H
Pathog Dis; 2022 Feb; 80(1):. PubMed ID: 35020898
[TBL] [Abstract][Full Text] [Related]
19. [Future prospects in developing of dengue vaccines].
Valero N; Levy A
Invest Clin; 2008 Jun; 49(2):135-8. PubMed ID: 18717261
[TBL] [Abstract][Full Text] [Related]
20. Dengue Vaccines: The Promise and Pitfalls of Antibody-Mediated Protection.
Martinez DR; Metz SW; Baric RS
Cell Host Microbe; 2021 Jan; 29(1):13-22. PubMed ID: 33444553
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
